Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Pavise ECMR for Ablative Resurfacing
NCT07462533Phase 2Not yet recruiting
- Sponsor
- Cosmetic Laser Dermatology
- Start
- Mar 2026
- Primary completion
- Jul 2026
01
Overview
Phase 2, randomised, open-label trial in Skin laxity and photodamage (2 arms), sponsored by Cosmetic Laser Dermatology. Primary endpoint: Investigator Evaluation of Erythema, Edema, Exudation and Crusting at Day 14. Planned start Mar 2026; status: not yet recruiting.
02
Conditions
Skin laxityphotodamage
Beyond the preview
Go deeper on NCT07462533.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07462533.